Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort.

Pellegrini C, Botta F, Massi D, Martorelli C, Facchetti F, Gandini S, Maisonneuve P, Avril MF, Demenais F, Bressac-de Paillerets B, Hoiom V, Cust AE, Anton-Culver H, Gruber SB, Gallagher RP, Marrett L, Zanetti R, Dwyer T, Thomas NE, Begg CB, Berwick M, Puig S, Potrony M, Nagore E, Ghiorzo P, Menin C, Manganoni AM, Rodolfo M, Brugnara S, Passoni E, Sekulovic LK, Baldini F, Guida G, Stratigos A, Ozdemir F, Ayala F, Fernandez-de-Misa R, Quaglino P, Ribas G, Romanini A, Migliano E, Stanganelli I, Kanetsky PA, Pizzichetta MA, García-Borrón JC, Nan H, Landi MT, Little J, Newton-Bishop J, Sera F, Fargnoli MC, Raimondi S; IMI Study Group; GEM Study Group; M-SKIP Study Group.

Lancet Child Adolesc Health. 2019 Mar 11. pii: S2352-4642(19)30005-7. doi: 10.1016/S2352-4642(19)30005-7. [Epub ahead of print]

PMID:
30872112
2.

Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT.

Taylor NJ, Mitra N, Qian L, Avril MF, Bishop DT, Paillerets BB, Bruno W, Calista D, Cuellar F, Cust AE, Demenais F, Elder DE, Gerdes AM, Ghiorzo P, Goldstein AM, Grazziotin TC, Gruis NA, Hansson J, Harland M, Hayward NK, Hocevar M, Höiom V, Holland EA, Ingvar C, Landi MT, Landman G, Larre-Borges A, Mann GJ, Nagore E, Olsson H, Palmer JM, Perić B, Pjanova D, Pritchard AL, Puig S, Schmid H, van der Stoep N, Tucker MA, Wadt KAW, Yang XR, Newton-Bishop JA, Kanetsky PA; GenoMEL Study Group.

J Am Acad Dermatol. 2019 Feb 4. pii: S0190-9622(19)30190-2. doi: 10.1016/j.jaad.2019.01.079. [Epub ahead of print]

PMID:
30731170
3.

Exploring the emotional and behavioural reactions to receiving personalized melanoma genomic risk information: a qualitative study.

Fenton GL, Smit AK, Keogh L, Cust AE.

Br J Dermatol. 2018 Dec 22. doi: 10.1111/bjd.17582. [Epub ahead of print]

PMID:
30580464
4.

Relationship of Chromosome Arm 10q Variants to Occurrence of Multiple Primary Melanoma in the Population-Based Genes, Environment, and Melanoma Study.

Miles JA, Orlow I, Kanetsky PA, Luo L, Cust AE, Armstrong BK, Kricker A, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Gibbs DC, Busam KJ, Mavinkurve V, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group.

J Invest Dermatol. 2018 Dec 17. pii: S0022-202X(18)32938-5. doi: 10.1016/j.jid.2018.11.030. [Epub ahead of print] No abstract available.

PMID:
30571972
5.

The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population-based data on diagnosis and management.

Guitera P, Collgros H, Madronio CM, Goumas C, Mann GJ, Watts CG, Pereira AR, Armstrong BK, Drummond M, Morton RL, Scolyer RA, Menzies SW, Thompson JF, Cust AE.

Australas J Dermatol. 2018 Oct 9. doi: 10.1111/ajd.12928. [Epub ahead of print]

PMID:
30302753
6.

Exercise as part of routine cancer care.

Cormie P, Adams D, Atkinson M, Bucci L, Cust AE, Eakin E, McCarthy AL, Murnane A, Quinn S, Hayes SC; Clinical Oncology Society of Australia Exercise and Cancer Group.

Lancet Oncol. 2018 Sep;19(9):e432. doi: 10.1016/S1470-2045(18)30598-9. No abstract available.

PMID:
30191842
7.

Melanoma - role of the environment and genetics.

Cust AE, Mishra K, Berwick M.

Photochem Photobiol Sci. 2018 Dec 5;17(12):1853-1860. doi: 10.1039/c7pp00411g. Review.

PMID:
30113042
8.

Why a randomized melanoma screening trial may be a good idea.

Cust AE, Aitken JF, Baade PD, Whiteman DC, Soyer HP, Janda M.

Br J Dermatol. 2018 Nov;179(5):1227-1228. doi: 10.1111/bjd.17089. Epub 2018 Sep 20. No abstract available.

PMID:
30101459
9.

Sunscreen Use and Melanoma Risk Among Young Australian Adults.

Watts CG, Drummond M, Goumas C, Schmid H, Armstrong BK, Aitken JF, Jenkins MA, Giles GG, Hopper JL, Mann GJ, Cust AE.

JAMA Dermatol. 2018 Sep 1;154(9):1001-1009. doi: 10.1001/jamadermatol.2018.1774.

PMID:
30027280
10.

Assessing the Incremental Contribution of Common Genomic Variants to Melanoma Risk Prediction in Two Population-Based Studies.

Cust AE, Drummond M, Kanetsky PA; Australian Melanoma Family Study Investigators; Leeds Case-Control Study Investigators, Goldstein AM, Barrett JH, MacGregor S, Law MH, Iles MM, Bui M, Hopper JL, Brossard M, Demenais F, Taylor JC, Hoggart C, Brown KM, Landi MT, Newton-Bishop JA, Mann GJ, Bishop DT.

J Invest Dermatol. 2018 Dec;138(12):2617-2624. doi: 10.1016/j.jid.2018.05.023. Epub 2018 Jun 8.

11.

The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviors.

Smit AK, Newson AJ, Morton RL, Kimlin M, Keogh L, Law MH, Kirk J, Dobbinson S, Kanetsky PA, Fenton G, Allen M, Butow P, Dunlop K, Trevena L, Lo S, Savard J, Dawkins H, Wordsworth S, Jenkins M, Mann GJ, Cust AE.

Contemp Clin Trials. 2018 Jul;70:106-116. doi: 10.1016/j.cct.2018.05.014. Epub 2018 May 23.

PMID:
29802966
12.

Personalized melanoma risk assessments and tailored prevention advice: a pragmatic randomized controlled trial in Australian general practice.

Vuong K, Armstrong BK, McGeechan K, Cust AE.

Fam Pract. 2019 Mar 20;36(2):237-246. doi: 10.1093/fampra/cmy040.

PMID:
29800131
13.

Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.

Thomas NE, Edmiston SN, Orlow I, Kanetsky PA, Luo L, Gibbs DC, Parrish EA, Hao H, Busam KJ, Armstrong BK, Kricker A, Cust AE, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Ollila DW, Begg CB, Berwick M, Conway K; GEM Study Group.

J Invest Dermatol. 2018 Nov;138(11):2398-2404. doi: 10.1016/j.jid.2018.04.025. Epub 2018 May 9.

14.

Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanoma.

Smit AK, Newson AJ, Best M, Badcock CA, Butow PN, Kirk J, Dunlop K, Fenton G, Cust AE.

Eur J Hum Genet. 2018 Aug;26(8):1094-1100. doi: 10.1038/s41431-018-0145-z. Epub 2018 Apr 30.

PMID:
29706632
15.

Polyunsaturated fatty acids and risk of melanoma: A Mendelian randomisation analysis.

Liyanage UE, Law MH, Ong JS, Cust AE, Mann GJ, Ward SV; Melanoma Meta-Analysis Consortium, Gharahkhani P, Iles MM, MacGregor S.

Int J Cancer. 2018 Aug 1;143(3):508-514. doi: 10.1002/ijc.31334. Epub 2018 Mar 5.

PMID:
29473154
16.

Prognostic features for acral lentiginous melanoma.

Cust AE.

Br J Dermatol. 2018 Feb;178(2):311-312. doi: 10.1111/bjd.16163. No abstract available.

PMID:
29441559
17.

Beyond country-specific incidence and mortality: the global burden of melanoma.

Bell KJL, Cust AE.

Br J Dermatol. 2018 Feb;178(2):315-316. doi: 10.1111/bjd.15688. No abstract available.

PMID:
29441534
18.

Validation of Questionnaire and Diary Measures of Time Outdoors Against an Objective Measure of Personal Ultraviolet Radiation Exposure.

Cust AE, Fenton GL, Smit AK, Espinoza D, Dobbinson S, Brodie A, Dang HTC, Kimlin MG.

Photochem Photobiol. 2018 Jul;94(4):815-820. doi: 10.1111/php.12893. Epub 2018 Mar 25.

PMID:
29421857
19.

A National Budget Impact Analysis of a Specialised Surveillance Programme for Individuals at Very High Risk of Melanoma in Australia.

Watts CG, Wortley S, Norris S, Menzies SW, Guitera P, Askie L, Mann GJ, Morton RL, Cust AE.

Appl Health Econ Health Policy. 2018 Apr;16(2):235-242. doi: 10.1007/s40258-017-0368-0.

PMID:
29305821
20.

Follow-Up Recommendations after Diagnosis of Primary Cutaneous Melanoma: A Population-Based Study in New South Wales, Australia.

Read RL, Madronio CM, Cust AE, Goumas C, Watts CG, Menzies S, Curtin AM, Mann G, Thompson JF, Morton RL.

Ann Surg Oncol. 2018 Mar;25(3):617-625. doi: 10.1245/s10434-017-6319-z. Epub 2018 Jan 3.

PMID:
29299710
21.

Development and Evaluation of a Telephone Communication Protocol for the Delivery of Personalized Melanoma Genomic Risk to the General Population.

Fenton GL, Smit AK, Freeman L, Badcock C, Dunlop K, Butow PN, Kirk J, Cust AE.

J Genet Couns. 2018 Apr;27(2):370-380. doi: 10.1007/s10897-017-0183-7. Epub 2017 Dec 3.

PMID:
29199389
22.

Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma.

Dieng M, Kasparian NA, Cust AE, Costa DSJ, Tran A, Butow PN, Menzies SW, Mann GJ, Morton RL.

JAMA Dermatol. 2018 Jan 1;154(1):52-59. doi: 10.1001/jamadermatol.2017.4701.

23.

The Importance of Population-Based Estimates of Melanocytic Pathology.

Bell KJL, Cust AE, Scolyer RA.

JAMA Dermatol. 2018 Jan 1;154(1):15-17. doi: 10.1001/jamadermatol.2017.4061. No abstract available.

PMID:
29094157
24.

The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival.

Orlow I, Shi Y, Kanetsky PA, Thomas NE, Luo L, Corrales-Guerrero S, Cust AE, Sacchetto L, Zanetti R, Rosso S, Armstrong BK, Dwyer T, Venn A, Gallagher RP, Gruber SB, Marrett LD, Anton-Culver H, Busam K, Begg CB, Berwick M; GEM Study Group.

Pigment Cell Melanoma Res. 2018 Mar;31(2):287-296. doi: 10.1111/pcmr.12653. Epub 2017 Nov 5.

25.

Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma.

Thomas NE, Edmiston SN, Kanetsky PA, Busam KJ, Kricker A, Armstrong BK, Cust AE, Anton-Culver H, Gruber SB, Luo L, Orlow I, Reiner AS, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Parrish EA, Hao H, Gibbs DC, Frank JS, Ollila DW, Begg CB, Berwick M, Conway K; GEM Study Group.

J Invest Dermatol. 2017 Dec;137(12):2588-2598. doi: 10.1016/j.jid.2017.07.832. Epub 2017 Aug 24.

26.

Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families.

Taylor NJ, Mitra N, Goldstein AM, Tucker MA, Avril MF, Azizi E, Bergman W, Bishop DT, Bressac-de Paillerets B, Bruno W, Calista D, Cannon-Albright LA, Cuellar F, Cust AE, Demenais F, Elder DE, Gerdes AM, Ghiorzo P, Grazziotin TC, Hansson J, Harland M, Hayward NK, Hocevar M, Höiom V, Ingvar C, Landi MT, Landman G, Larre-Borges A, Leachman SA, Mann GJ, Nagore E, Olsson H, Palmer JM, Perić B, Pjanova D, Pritchard A, Puig S, van der Stoep N, Wadt KAW, Whitaker L, Yang XR, Newton Bishop JA, Gruis NA, Kanetsky PA; GenoMEL Study Group.

J Invest Dermatol. 2017 Dec;137(12):2606-2612. doi: 10.1016/j.jid.2017.07.829. Epub 2017 Aug 19.

27.

Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma.

Vernali S, Waxweiler WT, Dillon PM, Kanetsky PA, Orlow I, Luo L, Busam KJ, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Cust AE, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group.

JAMA Dermatol. 2017 Oct 1;153(10):1026-1031. doi: 10.1001/jamadermatol.2017.2444.

28.

Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas.

Gibbs DC, Ward SV, Orlow I, Cadby G, Kanetsky PA, Luo L, Busam KJ, Kricker A, Armstrong BK, Cust AE, Anton-Culver H, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group.

Br J Dermatol. 2017 Nov;177(5):e180-e182. doi: 10.1111/bjd.15784. Epub 2017 Oct 6. No abstract available.

29.

Does personalized melanoma genomic risk information trigger conversations about skin cancer prevention and skin examination with family, friends and health professionals?

Smit AK, Keogh LA, Newson AJ, Butow PN, Dunlop K, Morton RL, Kirk J, Espinoza D, Cust AE.

Br J Dermatol. 2017 Sep;177(3):779-790. doi: 10.1111/bjd.15744. Epub 2017 Jul 20.

PMID:
28627002
30.

Poor Adherence to National Clinical Management Guidelines: A Population-Based, Cross-Sectional Study of the Surgical Management of Melanoma in New South Wales, Australia.

Varey AHR, Madronio CM, Cust AE, Goumas C, Mann GJ, Armstrong BK, Scolyer RA, Curtin AM, Thompson JF.

Ann Surg Oncol. 2017 Aug;24(8):2080-2088. doi: 10.1245/s10434-017-5890-7. Epub 2017 May 25.

PMID:
28547563
31.

Shared decision making in Australia in 2017.

Trevena L, Shepherd HL, Bonner C, Jansen J, Cust AE, Leask J, Shadbolt N, Del Mar C, McCaffery K, Hoffmann T.

Z Evid Fortbild Qual Gesundhwes. 2017 Jun;123-124:17-20. doi: 10.1016/j.zefq.2017.05.011. Epub 2017 May 18. Review.

32.

Estimating the future health service burden of keratinocyte cancers in the U.K.

Cust AE.

Br J Dermatol. 2017 May;176(5):1107-1108. doi: 10.1111/bjd.15476. No abstract available.

PMID:
28504381
34.

Increasing prevalence but not incidence of psoriasis in the U.K.

Cust AE, Murrell DF.

Br J Dermatol. 2017 Mar;176(3):568-569. doi: 10.1111/bjd.15331. No abstract available.

PMID:
28300313
35.

Cost-Effectiveness of Skin Surveillance Through a Specialized Clinic for Patients at High Risk of Melanoma.

Watts CG, Cust AE, Menzies SW, Mann GJ, Morton RL.

J Clin Oncol. 2017 Jan;35(1):63-71. Epub 2016 Oct 28.

PMID:
28034073
36.

Psychoeducational Intervention to Reduce Fear of Cancer Recurrence in People at High Risk of Developing Another Primary Melanoma: Results of a Randomized Controlled Trial.

Dieng M, Butow PN, Costa DS, Morton RL, Menzies SW, Mireskandari S, Tesson S, Mann GJ, Cust AE, Kasparian NA.

J Clin Oncol. 2016 Dec 20;34(36):4405-4414. Epub 2016 Oct 28.

PMID:
27998215
37.

Protocol for a within-trial economic evaluation of a psychoeducational intervention tailored to people at high risk of developing a second or subsequent melanoma.

Dieng M, Cust AE, Kasparian NA, Butow P, Costa DS, Menzies SW, Mann GJ, Morton RL.

BMJ Open. 2016 Oct 6;6(10):e012153. doi: 10.1136/bmjopen-2016-012153.

38.

Clinical Features Associated With Individuals at Higher Risk of Melanoma: A Population-Based Study.

Watts CG, Madronio C, Morton RL, Goumas C, Armstrong BK, Curtin A, Menzies SW, Mann GJ, Thompson JF, Cust AE.

JAMA Dermatol. 2017 Jan 1;153(1):23-29. doi: 10.1001/jamadermatol.2016.3327.

PMID:
27829101
39.

"Melanoma: Questions and Answers." Development and evaluation of a psycho-educational resource for people with a history of melanoma.

Kasparian NA, Mireskandari S, Butow PN, Dieng M, Cust AE, Meiser B, Barlow-Stewart K, Menzies S, Mann GJ.

Support Care Cancer. 2016 Dec;24(12):4849-4859. Epub 2016 Jul 27.

PMID:
27465047
40.

A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public.

Smit AK, Espinoza D, Newson AJ, Morton RL, Fenton G, Freeman L, Dunlop K, Butow PN, Law MH, Kimlin MG, Keogh LA, Dobbinson SJ, Kirk J, Kanetsky PA, Mann GJ, Cust AE.

Cancer Epidemiol Biomarkers Prev. 2017 Feb;26(2):212-221. doi: 10.1158/1055-9965.EPI-16-0395. Epub 2016 Oct 4.

41.

Variants in autophagy-related genes and clinical characteristics in melanoma: a population-based study.

White KA, Luo L, Thompson TA, Torres S, Hu CA, Thomas NE, Lilyquist J, Anton-Culver H, Gruber SB, From L, Busam KJ, Orlow I, Kanetsky PA, Marrett LD, Gallagher RP, Sacchetto L, Rosso S, Dwyer T, Cust AE, Begg CB, Berwick M; GEM Study Group.

Cancer Med. 2016 Nov;5(11):3336-3345. doi: 10.1002/cam4.929. Epub 2016 Oct 17.

42.

Doctors' recognition and management of melanoma patients' risk: An Australian population-based study.

Madronio CM, Armstrong BK, Watts CG, Goumas C, Morton RL, Curtin A, Menzies SW, Mann GJ, Thompson JF, Cust AE.

Cancer Epidemiol. 2016 Dec;45:32-39. doi: 10.1016/j.canep.2016.09.006. Epub 2016 Sep 28.

PMID:
27689254
43.

Physical Activity Correlates, Barriers, and Preferences for Women With Gynecological Cancer.

Farrokhzadi L, Dhillon HM, Goumas C, Young JM, Cust AE.

Int J Gynecol Cancer. 2016 Oct;26(8):1530-7. doi: 10.1097/IGC.0000000000000790.

PMID:
27488217
44.

Diagnosis and clinical management of melanoma patients at higher risk of a new primary melanoma: A population-based study in New South Wales, Australia.

Watts CG, Madronio CM, Morton RL, Goumas C, Armstrong BK, Curtin A, Menzies SW, Mann GJ, Thompson JF, Cust AE.

Australas J Dermatol. 2017 Nov;58(4):278-285. doi: 10.1111/ajd.12530. Epub 2016 Aug 1.

PMID:
27477217
45.

Development and External Validation of a Melanoma Risk Prediction Model Based on Self-assessed Risk Factors.

Vuong K, Armstrong BK, Weiderpass E, Lund E, Adami HO, Veierod MB, Barrett JH, Davies JR, Bishop DT, Whiteman DC, Olsen CM, Hopper JL, Mann GJ, Cust AE, McGeechan K; Australian Melanoma Family Study Investigators.

JAMA Dermatol. 2016 Aug 1;152(8):889-96. doi: 10.1001/jamadermatol.2016.0939.

46.

Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma.

Taylor NJ, Thomas NE, Anton-Culver H, Armstrong BK, Begg CB, Busam KJ, Cust AE, Dwyer T, From L, Gallagher RP, Gruber SB, Nishri DE, Orlow I, Rosso S, Venn AJ, Zanetti R, Berwick M, Kanetsky PA; GEM Study Group.

Int J Cancer. 2016 Sep 15;139(6):1217-22. doi: 10.1002/ijc.30157. Epub 2016 May 30.

47.

Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.

Gibbs DC, Orlow I, Bramson JI, Kanetsky PA, Luo L, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Sharma A, La Pilla E, From L, Busam KJ, Cust AE, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group.

J Natl Cancer Inst. 2016 Feb 8;108(7). pii: djw004. doi: 10.1093/jnci/djw004. Print 2016 Jul.

48.

Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families.

Taylor NJ, Handorf EA, Mitra N, Avril MF, Azizi E, Bergman W, Bianchi-Scarrà G, Bishop DT, Bressac-de Paillerets B, Calista D, Cannon-Albright LA, Cuellar F, Cust AE, Demenais F, Elder DE, Friedman E, Gerdes AM, Ghiorzo P, Goldstein AM, Grazziotin TC, Hansson J, Hayward NK, Hocevar M, Höiom V, Holland EA, Ingvar C, Landi MT, Landman G, Larre-Borges A, Leachman SA, Mann GJ, Nagore E, Olsson H, Palmer J, Perić B, Pjanova D, Puig S, Schmid H, van der Stoep N, Tucker MA, Wadt KAW, Whitaker L, Yang XR, Newton Bishop JA, Gruis NA, Kanetsky PA; GenoMEL Consortium.

J Invest Dermatol. 2016 May;136(5):1066-1069. doi: 10.1016/j.jid.2016.01.009. Epub 2016 Jan 28. No abstract available.

49.

Economic evaluations of psychosocial interventions in cancer: a systematic review.

Dieng M, Cust AE, Kasparian NA, Mann GJ, Morton RL.

Psychooncology. 2016 Dec;25(12):1380-1392. doi: 10.1002/pon.4075. Epub 2016 Jan 26. Review.

PMID:
26810383
50.

Psychometric properties of the Fear of Cancer Recurrence Inventory: an item response theory approach.

Costa DS, Dieng M, Cust AE, Butow PN, Kasparian NA.

Psychooncology. 2016 Jul;25(7):832-8. doi: 10.1002/pon.4018. Epub 2015 Oct 22.

PMID:
26489770

Supplemental Content

Support Center